Suchergebnisse - "Cancer"

PubPharm (1.281.898)

31

Prospects and challenges of CAR-T in the treatment of ovarian cancer

enthalten in: International immunopharmacology | 2024

von Chen, B. | Liu, J.

32

Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer

enthalten in: International immunopharmacology | 2024

von Bao, L. | Li, Y. | Hu, X. | +6

33

The potential role of SNHG16/ miRNA-146a/ TRAF6 signaling pathway in the protective effect of zoledronate against colorectal cancer and associated osteoporosis in mouse model

enthalten in: International immunopharmacology | 2024

von Helmy Mohamed, A. | Noureldin Hassan, A. | Hussein Abdel Hay, N. | +4

34

The quantity, function and anti-tumor effect of Mucosal associated invariant T cells in patients with bladder cancer

enthalten in: International immunopharmacology | 2024

von Zhang, B. | Chen, P. | Zhu, J. | +1

35

IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer

enthalten in: International immunopharmacology | 2024

von Li, L. | Fei, Y. | Dong, T. | +6

36

Extracellular vesicles derived from immune cells : Role in tumor therapy

enthalten in: International immunopharmacology | 2024

von Shi, Y. | Yao, F. | Yin, Y. | +7

37

IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer : From bench to bedside

enthalten in: International immunopharmacology | 2024

von Vahidi, S. | Zabeti Touchaei, A. | Samadani, A.

38

An extensive overview of the role of lncRNAs generated from immune cells in the etiology of cancer

enthalten in: International immunopharmacology | 2024

von Luo, H. | Jing, H. | Chen, W.

39

IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development

enthalten in: Cellular signalling | 2024

von Chen, W. | Xie, X. | Liu, C. | +4

40

Phase 1b trial of anti-HER2 antibody inetetamab and pan-HER inhibitor pyrotinib in HER2-positive advanced lung cancer

enthalten in: MedComm | 2024

von Huang, Y. | Zhao, Y. | Huang, Y. | +12